Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Digital revista |
| Idioma: | English |
| Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2014
|
| Acceso en línea: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000400499 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|